Logo

PharmaShots Weekly Snapshot (Jun 22- 26, 2020)

Share this

PharmaShots Weekly Snapshot (Jun 22- 26, 2020)

 1.  EMA’s CHMP Recommends the Approval of Two Biosimilar Referencing Lilly’s Forsteo (teriparatide) for the Treatment of Osteoporosis

Published: Jun 26, 2020 | Tags: EMA, CHMP, Recommend, Approval, Two, Biosimilar, Referencing, Lilly, Forsteo, teriparatide, Osteoporosis

2.  Medtronic Receives the US FDA’s Approval for its Percept PC Neurostimulator with BrainSense Technology

Published: Jun 25, 2020 | Tags: Medtronic, Receives, US, FDA, Approval, Percept PC Neurostimulator, BrainSense Technology

 3. Sandoz Launches the Biosimilars Generation Campaign in Canada

Published: Jun 25, 2020 | Tags: Sandoz, Launches, Biosimilars Generation Campaign, Canada

4.  Roche Launches uPath PD-L1 (SP263) Automated Digital Pathology Algorithm to Speed Up NSCLC Diagnosis

Published: Jun 26, 2020 | Tags: Roche, Launches, uPath PD-L1, SP263, Automated, Digital Pathology Algorithm, Speed Up, NSCLC Diagnosis

5. EMA Anticipates the EC’s Conditional Marketing Authorization for Gilead’s Remdesivir in Coming Week

Published: Jun 25, 2020 | Tags: EMA, Anticipates, EC, Conditional Marketing Authorization, Gilead, Remdesivir, Imminently

6.  Zogenix’s Fintepla (fenfluramine) Receives the US FDA’s Approval for the Treatment of Seizures Associated with Dravet Syndrome

Published: Jun 25, 2020 | Tags: Zogenix, Fintepla, fenfluramine, Receives, US, FDA, Approval, Treatment, Seizures, Associated, Dravet Syndrome

7.  AbbVie Signs an Exclusive Research and Option to License Agreement with Sosei Heptares Targeting Inflammatory and Autoimmune Diseases

Published: Jun 25, 2020 | Tags: AbbVie, Signs, Exclusive, Research, Option to License, Agreement, Sosei Heptares, Targeting, Inflammatory, Autoimmune Diseases

8.  Theravance Reports First Patient Dosing in a P-II Study of TD-0903 for Hospitalized Patients with Acute Lung Injury Associated with COVID-19

Published: Jun 25, 2020 | Tags: Theravance, Reports, First, Patients, Dosing, P-II Study, TD-0903, Hospitalized, Patients, Acute Lung Injury, Associated, COVID-19

9. Fulcrum Initiates P-III LOSVID Study Evaluating Losmapimod for Patients Hospitalized with COVID-19

Published: Jun 25, 2020 | Tags: Fulcrum, Initiates, P-III, LOSVID, Study, Evaluating, Losmapimod, Patients, Hospitalized, COVID-19

10.  Merck’s Keytruda (pembrolizumab) Receives the US FDA’s Approval for Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma

Published: Jun 24, 2020 | Tags: Merck, Keytruda, pembrolizumab, Receives, US, FDA, Approval, Patients, Recurrent, Metastatic, Cutaneous Squamous Cell Carcinoma

11.  AstraZeneca Reports Results of Breztri Aerosphere in P-III ETHOS Study to Treat COPD

Published: Jun 24, 2020 | Tags: AstraZeneca, Reports, Results, Breztri Aerosphere, P-III, ETHOS Study, Treat, COPD

12.  Merck Collaborates with Yumanity to Accelerate the Development of Two Therapies Targeting Neurodegenerative Diseases

Published: Jun 24, 2020 | Tags: Merck, Collaborates, Yumanity, Accelerate, Development, Two, Therapies, Targeting, Neurodegenerative Diseases

13.  CSL Behring to Acquire uniQure’ Hemophilia B Candidate (AMT-061) for ~$2B

Published: Jun 24, 2020 | Tags: CSL Behring, Acquire, uniQure, Heamophilia B, Candidate, AMT-061, ~$2B

14.   FibroGen Report Enrollment of First Patient in P-II Study Evaluating Pamrevlumab in Patients Hospitalized with Acute COVID-19

Published: Jun 24, 2020 | Tags: FibroGen, Report, Enrollment, First Patient, P-II, Study, Evaluating, Pamrevlumab, Patients, Hospitalized, Acute, COVID-19

15.   The US FDA Launches Project Patient Voice to Share Patient-Reported Outcomes from Cancer Trials

Published: Jun 24, 2020 | Tags: US, FDA, Launches, Project Patient Voice, Share, Patient Reported Outcomes, Cancer Trials

16.   AstraZeneca Signs an Agreement with Symbiosis for Sterile Manufacturing of its AZD1222 Against COVID-19

Published: Jun 24, 2020 | Tags: AstraZeneca, Signs, Agreement, Symbiosis, Sterile Manufacturing, AZD1222, Against, COVID-19

17. Sarepta Signs a Two-Year Research and Option Agreement with Codiak for Up to Five Neuromuscular Targets

Published: Jun 24, 2020 | Tags: Sarepta, Signs, Two-Year, Research and Option, Agreement, Codiak, Up to, Five, Neuromuscular Targets

18. Gilead Holds an Exclusive Option to Acquire Pionyr Immunotherapeutics for ~$1.75B

Published: Jun 24, 2020 | Tags: Gilead, Holds, Exclusive, Option to Acquire, Pionyr Immunotherapeutics, ~$1.75B

19.  Sanofi Anticipates the Approval of its COVID-19 Vaccine by First Half of 2021

Published: Jun 23, 2020 | Tags: Sanofi, Anticipates, Approval, COVID-19, Vaccine, First Half, 2021

20.   Schrodinger Expands its Drug Discovery Efforts Against COVID-19 Deploying Parallel Computing on Google Cloud

Published: Jun 23, 2020 | Tags: Schrödinger, Expands, Drug Discovery, Efforts, Against, COVID-19, Deploying, Parallel Computing, Google Cloud

21. BioInvent Reports the Enrollment of First Patient in P-I/IIa Study of BI-1206 + Keytruda for Solid Tumors

Published: Jun 23, 2020 | Tags: BioInvent, Reports, Enrollment, P-I/IIa, Study, BI-1206, Keytruda, Solid Tumors

22.  ATAI Launches IntroSpect Digital Therapeutics to Foster Mental Health Care

Published: Jun 22, 2020 | Tags: ATAI, Launches, IntroSpect Digital Therapeutics, Foster, Mental Health Care

23. AbbVie Reports the US FDA’s Acceptance of BOTOX’s sBLA for Pediatric Patients with Neurogenic Detrusor Overactivity

Published: Jun 22, 2020 | Tags: AbbVie, Reports, US, FDA, Acceptance, BOTOX, sBLA, Pediatric Patients, Neurogenic Detrusor Overactivity

24.  Sanofi Expands its 2018 Collaboration with Translate Bio to Develop mRNA Vaccines Against Infectious Diseases

Published: Jun 22, 2020 | Tags:  Sanofi, Expands, 2018, Collaboration, Translate Bio, develop, mRNA, Vaccines, Against, Infectious Diseases

25.  Gilead to Initiate P-I Study Evaluating Inhaled Version of Remedesivir Against COVID-19 in August 2020

Published: Jun 22, 2020 | Tags: Gilead, Initiate, P-I, Study, Evaluating, Inhaled Version, Remedesivir, Against, COVID-19, August, 2020

26.  Merck’s Keytruda Receives the NMPA’s Approval as a 2L Treatment for Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Published: Jun 21, 2020 | Tags: Foundation Medicine, Acquires, Lexent, Expand, Liquid Biopsy Platforms

27. Cipla Launches Cipremi (remdesivir lyophilized powder for injection 100 mg) to Treat Patients with Severe COVID-19

Published: Jun 20, 2020 | Tags: Cipla, Launches, Cipremi, Remdesivir, Patients, COVID-19

28. Novartis Halts Clinical Trial Evaluating Hydroxychloroquine Against COVID-19 Due to Slow Enrollment

Published: Jun 20, 2020 | Tags: Eli Lilly, Initiates, P-III, Study, Evaluating, Baricitinib, Hospitalized, Patients, COVID-19

29.  Merck KGaA and Pfizer Report EMA’s Validation for Bavencio (avelumab) as a 1L Treatment for Locally Advanced or Metastatic Urothelial Carcinoma

Published: Jun 21, 2020 | Tags: Gilead, Signs, License Agreement, Zydus, Dr. Reddy’s, Remdesivir, Treat, COVID-19

30. Glenmark Launches FabiFlu (favipiravir) as the First Oral Medication to Treat Mild to Moderate COVID-19 in India

Published: Jun 21, 2020 | Tags: AstraZeneca, Supply, 400M, Doses, Vaccines, IVA, End, 2020


Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions